As demonstrated in Fig. 4A, the most frequent cancer-related mutations [35] were found in PIK3CA (39%), TP53 (27%), KMT2C (16%), MUC16 (16%), CDH1 (13%), GATA3 (13%). Here, MUC16 is linked to cancer.